Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
Authors:
- Justin TaylorJTJustin Taylor
- Mark T.A. DonoghueMDMark T.A. Donoghue
- Caleb HoCHCaleb Ho
- Kseniya Petrova-DrusKPKseniya Petrova-Drus
- Hikmat A. Al-AhmadieHAHikmat A. Al-Ahmadie
- Samuel A. FuntSFSamuel A. Funt
- Yanming ZhangYZYanming Zhang
- Umut AyparUAUmut Aypar
- Shweta S. ChavanSCShweta S. Chavan
- Michael HaddadinMHMichael Haddadin
- Roni TamariRTRoni Tamari
- 1 December 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 130 (12) , 6668-6676
Abstract
Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes. One in every 17 patients with primary mediastinal nonseminomatous GCTs develop an incurable hematologic malignancy and prior data intriguingly suggest a clonal relationship exists between hematologic malignancies and GCTs in these cases. To date, however, the precise clonal relationship between GCTs and the diverse additional somatic malignancies arising in such individuals have not been determined. Here, we traced the clonal evolution and characterized the genetic features of each neoplasm from a cohort of 15 patients with GCTs and associated hematologic malignancies. We discovered that GCTs and hematologic malignancies developing in such individuals evolved from a common shared precursor, nearly all of which harbored allelically imbalanced p53 and/or RAS pathway mutations. Hematologic malignancies arising in this setting genetically resembled mediastinal GCTs rather than de novo myeloid neoplasms. Our findings argue that this scenario represents a unique clinical syndrome, distinct from de novo GCTs or hematologic malignancies, initiated by an ancestral precursor that gives rise to the parallel evolution of GCTs and blood cancers in these patients.Keywords
Funding Information
- National Cancer Institute (1K08CA230319-01)
- National Cancer Institute (P30 CA008748)
This publication has 29 references indexed in Scilit:
- Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)The Journal of Molecular Diagnostics, 2015
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolutionScience Translational Medicine, 2015
- Testicular Cancer — Discoveries and UpdatesNew England Journal of Medicine, 2014
- Acquired isochromosome 12p, somatic TP53 and PTEN mutations, and a germline ATM variant in an adolescent male with concurrent acute megakaryoblastic leukemia and mediastinal germ cell tumorCancer Genetics, 2014
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid LeukemiaNew England Journal of Medicine, 2013
- Hematologic Disorders Associated With Primary Mediastinal Nonseminomatous Germ Cell TumorsJNCI: Journal of the National Cancer Institute, 2000
- Cytogenetic and Immunohistochemical Evidence for the Germ Cell Origin of a Subset of Acute Leukemias Associated With Mediastinal Germ Cell TumorsJNCI: Journal of the National Cancer Institute, 1990
- Leukemic differentiation of a mediastinal germ cell tumorGenes, Chromosomes and Cancer, 1989
- Association between mediastinal germ cell tumors and hematologic malignanciesAmerican Journal of Surgical Pathology, 1985